The estimated Net Worth of Donald Darkin is at least 9.44 百万$ dollars as of 11 November 2015. Donald Darkin owns over 25,442 units of Resmed stock worth over 3,460,957$ and over the last 15 years Donald sold RMD stock worth over 5,978,842$.
Sign up
Donald Darkin RMD stock SEC Form 4 insiders trading
Donald has made over 15 trades of the Resmed stock since 2010, according to the Form 4 filled with the SEC. Most recently Donald sold 25,442 units of RMD stock worth 1,468,512$ on 11 November 2015.
The largest trade Donald's ever made was exercising 32,000 units of Resmed stock on 30 November 2011 worth over 507,520$. On average, Donald trades about 12,398 units every 81 days since 2010. As of 11 November 2015 Donald still owns at least 13,684 units of Resmed stock.
You can see the complete history of Donald Darkin stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Resmed
Over the last 23 years, insiders at Resmed have traded over 250,830,262$ worth of Resmed stock and bought 10,000 units worth 424,500$ . The most active insiders traders include Peter C Farrell、Gary W Pace、David Pendarvis. On average, Resmed executives and independent directors trade stock every 7 days with the average trade being worth of 3,005,701$. The most recent stock trade was executed by Brett Sandercock on 9 September 2024, trading 1,000 units of RMD stock currently worth 246,420$.
What does Resmed do?
at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
What does Resmed's logo look like?
Complete history of Donald Darkin stock trades at Resmed
Resmed executives and stock owners
Resmed executives and other stock owners filed with the SEC include:
-
Michael Farrell,
Chief Executive Officer, Director -
Robert Douglas,
President, Chief Operating Officer -
Jim Hollingshead,
President – sleep and respiratory care business -
Rajwant Sodhi,
President – Software as a Service Business (SaaS) -
Brett Sandercock,
Chief Financial Officer -
Michael J. Farrell BE, SM, MBA,
CEO & Director -
David Pendarvis,
Chief Administrative Officer, Global General Counsel, Secretary -
Michael J. Farrell BE, MBA, SM,
CEO & Director -
Robert A. Douglas,
Pres & COO -
Dr. James R. Hollingshead Ph.D.,
Pres of Sleep & Respiratory Care Bus. -
Brett A. Sandercock,
Chief Financial Officer -
Peter Farrell,
Non-Executive Chairman of the Board -
Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD,
Founder & Non-Exec. Chairman -
Dr. Peter C. Farrell A.M., B.E., Ph.D., BE (Hons), ScD, AM,
Founder & Non-Exec. Chairman -
Ronald Taylor,
Lead Independent Director -
Carol Burt,
Independent Director -
Richard Sulpizio,
Independent Director -
Harjit Gill,
Independent Director -
Jan De Witte,
Independent Director -
Karen Drexler,
Independent Director -
Justin Leong,
President – Asia and Latin America -
Urvashi Tyagi,
Chief Technology Officer -
Nupur Bhushan,
Chief People Officer -
David B. Pendarvis,
Chief Admin. Officer, Global Gen. Counsel & Corp. Sec. -
Amy Wakeham,
VP of Investor Relations & Corp. Communications -
Constance C. Bienfait,
Director of Investor Relations -
Kaushik Ghoshal,
Pres of SaaS Bus. & CTO -
John P Wareham,
Director -
Christopher G Roberts,
Director -
Donald Darkin,
Sr. Vice President, Pat Inter -
Gary W Pace,
Director -
Anne Reiser,
President - ResMed Europe -
Richard Mc Hale,
President, RC Business -
Inc Resmed,
Director -
James Hollingshead,
President, Sleep Business -
Kieran Gallahue,
President, Global -
Paul Eisen,
Vice President, Europe & Asia -
Donagh Mccarthy,
Director -
Adrian M Smith,
CFO -
Klaus H Shindhelm,
Sr. Vice President, Operations -
Keith Serzen,
Chief Operating Officer -
Louis A Simpson,
Director -
Christopher Bartlett,
Director -
Walter Flicker,
VP and Asst. Corp. Secretary -
Lasse Beijer,
COO-Europe -
Stein Jacobsen,
COO, Europe -
Michael A Quinn,
Director -
Kaushik Ghoshal,
President, SaaS Business -
Lucile Blaise,
President, Sleep & RC Business -
John Hernandez,
Director -
Desney Tan,
Director -
Michael J Rider,
Global General Counsel -
Christopher Del Orefice,
Director